Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Lilly 127935

Known as: Ly 127935, Ly-127935, Ly127935 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1981
Highly Cited
1981
To measure the susceptibility of penicillin-resistant pneumococci to newer beta-lactam agents, we evaluated 54 selected strains… Expand
Highly Cited
1980
Highly Cited
1980
The practical application of thienamycin, a novel beta-lactam antibiotic with a broad activity spectrum, was compromised by… Expand
Highly Cited
1980
Highly Cited
1980
This study compares the minimum inhibitory concentrations of cefoperazone, cefotaxime, and moxalactam (LY127935) for 446 aerobic… Expand
Highly Cited
1980
Highly Cited
1980
Minimum inhibitory concentrations and agar disk diffusion tests were determined on clinical isolates of beta-lactamase-positive… Expand
Highly Cited
1980
Highly Cited
1980
A total of 91 multiply resistant bacterial strains, including Klebsiella pneumoniae (32 strains), Pseudomonas aeruginosa (16… Expand
Highly Cited
1980
Highly Cited
1980
Moxalactam (LY127935) is a 1-oxa-beta-lactam which was active in vitro against the majority of 128 strains of gram-negative… Expand
1980
1980
Moxalactam (LY127935) exhibited greater in vitro activity than cefamandole and tobramycin against clinical isolates of… Expand
Highly Cited
1979
Highly Cited
1979
Pseudomonas maltophilia is resistant to most of the commonly used antimicrobial agents including those active against Pseudomonas… Expand
Highly Cited
1979
Highly Cited
1979
The in vitro activity of LY-127935, a new beta-lactam antibiotic, was examined by using 370 clinical bacterial strains. In… Expand
1979
1979
The activity of LY127935, a beta-lactam antibiotic of novel structure, was studied in vitro against facultative gram-negative… Expand